Comparison of serum apolipoprotein A-I between Chinese multiple sclerosis and other related autoimmune disease

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Zhang, Bin ^a,b   Pu, Shuxiang ^a,b   Li, Binmei ^a,b   Ying, Jianrui ^a,b   Song, Xing Wang ^a,b   Gao, Cong ^a,b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b Guangzhou Medical University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; LIPID; LIPOPROTEIN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHINESE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; FEMALE; GENDER; GUILLAIN BARRE SYNDROME; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS ENCEPHALITIS; AGE; ASIAN; BLOOD; CASE CONTROL STUDY; DEMYELINATING DISEASE; MIDDLE AGED; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADULT; AGE FACTORS; APOLIPOPROTEIN A-I; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; DEMYELINATING DISEASES; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 77951684515     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-34     Document Type: Article

References (36)

1. Normal lipid metabolism, familial hyperlipidaemia, lipid intervention and theirbenefits. BC Koner K Goswami S Kavitha RS Moorthy, J Indian Med Assoc 2003 101 2 89 92 Review 12841490
2. Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway. AT Remaley F Thomas JA Stonik, J Lipid Res 2003 44 828 36 10.1194/jlr.M200475-JLR200 12562845
3. High-dose recombinant apolipoproteinA-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization. PK Shah J Yano O Reyes, Circulation 2001 103 3047 50 10.1161/hc2501.092494 11425766
4. Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. LO Martinez B Agerholm-Larsen N Wang W Chen AR Tall, Biol Chem 2003 278 37368 74 10.1074/jbc.M307161200 (Pubitemid 37175255)
5. Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo. Y Zhang I Zanotti MP Reilly JM Glick GH Rothblat DJ Rader, Circulation 2003 108 661 63 10.1161/01.CIR. 0000086981.09834.E0 12900335
6. High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation? D Burger JM Dayer, Autoimmun Rev 2002 1 111 7 10.1016/S1568-9972(01)00018-0 12849067
7. Apolipoprotein A-I inhibits the production of interleukin-1b and tumor necrosis factor-a by blocking contact-mediated activation of monocytes by T lymphocytes. N Hyka JM Dayer C Modoux T Kohno C K Edwards III, et al. Blood 2001 97 2381 8 10.1182/blood.V97.8.2381 11290601
8. Apolipoprotein A-I-dependent cholesterol esterification in patients with rheumatoid arthritis. L Cigliano MS Spagnuoloa G Cuomo, et al. Life Sci 2005 77 108 20 10.1016/j.lfs.2004.12.023 15848223
9. Lipoprotein (a) levels, apolipoprotein(a) phenotypes and thyroid autoimmunity. E Bairaktari AD Tselepis HJ Millionis MS Elisaf, Eur J Endocrinol 1999 140 474 6 10.1530/eje.0.1400474 10229916
10. New insights into responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis. M El Behi S Dubucquoi D Lefranc, et al. Immunol Lett 2005 96 11 26 10.1016/j.imlet.2004.07.017 15585303
11. Mast cells: new targets for multiple sclerosis therapy? JP Zappulla M Arock LT Mars, et al. J Neuroimmunol 2002 131 5 20 10.1016/S0165-5728(02)00250-3 12458032
12. Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis. S Desplat-Jégo R Creidy S Varriale N Allaire, et al. Clin Immunol 2005 117 15 25 10.1016/j.clim.2005.06.005 16027043
13. Roles of TNF-Related Apoptosis-Inducing Ligand in Experimental Autoimmune Encephalomyelitis. B Hilliard A Wilmen C Seidel TS Liu, et al. J Immunol 2001 166 1314 19 11145715
14. Proinflammatory Effects of Tweak/Fn14 Interactions in Glomerular Mesangial Cells. S Campbell LC Burkly HX Gao JW Berman, et al. J Immunol 2006 176 1889 98 16424220
15. Thecontact-mediated response of peripheral-blood monocytes to preactivated T cells is suppressed by serum factors in rheumatoid arthritis. M Rossol S Kaltenhäuser R Scholz, et al. Arthritis Res Ther 2005 7 1189 99 10.1186/ar1804
16. Apolipoprotein A-IV inhibits experimental colitis. T Vowinkel M Mori C Krieglstein, et al. J Clin Invest 2004 114 260 9 15254593
17. Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE. AR Dinu JT Merrill C Shen, Lupus 1998 7 5 355 360 10.1191/096120398678920262 9696140
18. Alterations in plasma lipoproteins and apolipoproteins in experimental allergic encephalomyelitis. VG Shore ME Smith V Perret MA Laskaris, J Lipid Res 1987 28 119 29 3494804
19. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. W McDonald A Compston G Edan, et al. Ann Neurol 2001 50 121 7 10.1002/ana.1032 11456302
20. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). JF Kurtzke, Neurology 1983 33 1444 52 6685237
21. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper LA Healey SR Kaplan MH Liang HS Luthra, et al. Arthritis Rheum 1988 31 315 24 10.1002/art.1780310302 3358796
22. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. MC Hochberg, Arthritis Rheum 1997 40 1725 10.1002/art.1780400928 9324032
23. Apolipoprotein E and multiple sclerosis: A biochemical and genetic investigation. O Gaillard A Gervai D Meillet E Plassart, et al. J Neurol Sci 1998 158 180 86 10.1016/S0022-510X(98)00118-X 9702689
24. Inhibitory cytokines and cytokine inhibitors. D Burger JM Dayer, Neurology 1995 45 39 43
25. Role of cytokines in rheumatoid arthritis. M Feldmann FM Brennan RN Maini, Annu Rev Immunol 1996 14 397 440 10.1146/annurev.immunol.14.1.397 8717520
26. Differential aspects of cytokines in the immunopathology of multiple sclerosis. K Lucas R Hohlfeld, Neurology 1995 45 4 5
27. The role of inflammation in vascular diseases. GW Sullivan IJ Sarembock J Linden, J Leukoc Biol 2000 67 591 602 10810997
28. How T lymphocytes recognize lipid antigens. DL Gennaro M Lucia, FEBS Letters 2006 580 5580 87 10.1016/j.febslet.2006.08.029 16949584
29. Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production? B Barry G Martina FG Oliver MD Jean, Arthritis Res Ther 2004 6 563 66 10.1186/ar1443
30. Anti-apolipoprotein A-I autoantibody: characterization of monoclonal autoantibodies from patients with systemic lupus erythematosus. H Abe N Tsuboi S Suzuki H Sakuraba, Rheumatol 2001 28 5 990 95
31. Inflammation and the pathogenesis of atherosclerosis in systemic lupus erythematosus. M McMahon J Grossman W Chen BH Hahn, Lupus 2006 15 59 69 10.1177/0961203306071668 16482750
32. Acute-phase proteins and other systemic responses to inflammation. C Gabay I Kushner, N Engl J Med 1999 340 448 54 10.1056/NEJM199902113400607 9971870
33. Anderson. Accumulation of Apolipoproteins in the Regenerating Remyelinating Mammalian Peripheral Nerve. KB Janet MN Lucia J Linda, J Biol Chem 1990 265 17805 15 2120218
34. High-density lipoprotein and cerebral endothelial cells in vitro: interactions and transport. HE De Vries B Breedveld J Kuiper AG de Boer TJ Van Berkel DD Breimer, Biochem Pharmaco 1995 50 271 3 10.1016/0006-2952(95)00127-L
35. Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin cholesterol acyl transferase in CSF of normal individuals and patients with Alzheimer's disease. G Demeester C Castro CD Desrumaux, J Lipid Res 2000 41 963 74 10828089
36. ApolipoproteinA-I Induces Translocation of Cholesterol, Phospholipid, and Caveolin-1 to Cytosol in Rat Astrocytes. Ito Jin-ichi Nagayasu Yuko Kato Koichi Sato Ryuichiro, J Biol Chem 2002 277 7929 35 10.1074/jbc.M103878200 11773045